Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Avanceña ALV

41 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 23 Review Article 17 Mechanism of Action 14 Clinical Trial 13 Safety 13 Treatment-Resistant Depression 11 Receptor Pharmacology 10 Systematic Review 8 Anxiety 7 Pharmacology 6 Drug Interactions 6 Randomized Controlled Trial 6

Journals

Journal of affective disorders 3 bioRxiv 2 European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 2 Frontiers in psychiatry 2 Journal of Affective Disorders 1 Human Brain Mapping 1 Journal of psychiatric research 1 Natural Product Research 1

Publication history

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01 Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic EvidencebioRxiv · 2026-07-27 Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01 Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-06-23 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-02 Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.European archives of psychiatry and clinical neuroscience · 2026-06-01 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10 Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15 Oregon's Psilocybin Services: A Summary and Public Health Commentary.Health behavior research · 2026-01-01 Preclinical evaluation of psilocybin as an anti-inflammatory agentNeuroscience Applied · 2026-01-01 Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.Palliative medicine · 2026-01-01 Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-AnalysesScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) · 2025-09-17 Lifetime classic psychedelic use and headaches: A cross-sectional study.Journal of psychopharmacology (Oxford, England) · 2025-09-01 Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.Translational psychiatry · 2025-08-29 Psilocybin: Systematic review of its use in the treatment of depressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2025-08-26 Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01 The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01 Alternative therapy for neurological and psychiatric disorders using psilocybinSão Paulo Medical Journal · 2025-01-01 Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07 Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.Brain sciences · 2024-08-18 Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2024-03-01 Is there credible evidence to assert psilocybin-assisted therapy for depression?European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2024-01-01 Use of Psychedelics for Pain: A Scoping Review.Anesthesiology · 2023-10-01 Self-perception and self-recognition while looking in the mirror on psilocybinJournal of Psychedelic Studies · 2023-09-19 Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.Journal of psychiatric practice · 2023-09-01 Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14 The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.Neurochemical research · 2023-04-01 Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023-03-22 Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.International journal of clinical and health psychology: IJCHP · 2023-01-01 Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01 Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03 A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.CNS drugs · 2022-10-01 Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-08 Psychedelic medicines for mood disorders: current evidence and clinical considerations.Current opinion in psychiatry · 2022-01-01 P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-12-01 Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01 Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.Cells · 2021-07-27 Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Psychopharmacology · 2021-02-01 Enhanced repertoire of brain dynamical states during the psychedelic experience.Human brain mapping · 2014-11-01 The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.Frontiers in human neuroscience · 2014-01-01

Author directory